MENU
NVCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NovoCure (NVCR) Earnings Date & Reports

NovoCure Ltd is an oncology company with a propreitary platform technology in United States... Show more

A.I. Advisor
published Earnings

NVCR is expected to report earnings to rise 18.61% to -42 cents per share on October 23

NovoCure NVCR Stock Earnings Reports
Q3'25
Est.
$-0.43
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.25
Q3'24
Beat
by $0.05
The last earnings report on July 24 showed earnings per share of -36 cents, beating the estimate of -37 cents. With 573.27K shares outstanding, the current market capitalization sits at 1.24B.
View a ticker or compare two or three
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVCR showed earnings on July 24, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a commercial-stage oncology company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Grenville Street
Phone
+44 1534756700
Employees
1453
Web
https://www.novocure.com